STOK
Closed
Stoke Therapeutics Inc
11.65
+0.30 (+2.64%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 11.35
Day's Range: 11.19 - 12.
Send
sign up or login to leave a comment!
When Written:
8.01
Stoke Therapeutics Inc. is a biotechnology company that was founded in 2018 and is headquartered in Bedford, Massachusetts. The company is focused on developing therapies for genetic diseases by targeting RNA. Stoke's approach is to increase the production of functional proteins that are missing or deficient in patients with genetic diseases by selectively upregulating gene expression.
The company's lead product candidate is STK-001, which is being developed for the treatment of Dravet syndrome, a rare and severe form of epilepsy that begins in infancy. STK-001 is designed to increase the production of the sodium channel Nav1.1, which is deficient in patients with Dravet syndrome. Stoke is also developing therapies for other genetic diseases, including genetic forms of Parkinson's disease and other neurological disorders.
Stoke Therapeutics is backed by leading venture capital firms, including Apple Tree Partners, RTW Investments, RA Capital Management, and Cormorant Asset Management. The company went public in June 2019 and is traded on the NASDAQ stock exchange under the ticker symbol STOK.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company's lead product candidate is STK-001, which is being developed for the treatment of Dravet syndrome, a rare and severe form of epilepsy that begins in infancy. STK-001 is designed to increase the production of the sodium channel Nav1.1, which is deficient in patients with Dravet syndrome. Stoke is also developing therapies for other genetic diseases, including genetic forms of Parkinson's disease and other neurological disorders.
Stoke Therapeutics is backed by leading venture capital firms, including Apple Tree Partners, RTW Investments, RA Capital Management, and Cormorant Asset Management. The company went public in June 2019 and is traded on the NASDAQ stock exchange under the ticker symbol STOK.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!